GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases
{ Posted on Feb 07 2010 by admin }
GSK announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet medical need. Despite the rarity of each condition, the number of diseases means that between 6-8% of the population(3) may be affected by a rare disease. Many are genetic in origin, start in childhood and cause lifelong debility and premature death…
Related posts:
- GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases GSK announces the formation of a new standalone unit specialising...
- GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases GSK announces the formation of a new standalone unit specialising...
- GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases GSK announces the formation of a new standalone unit specialising...
- Web-Based Tool Predicts The Molecular Causes Of Many Genetic Diseases It is widely known that genetic mutations cause disease. What...
- Scientists Confirm Rare Genetic Mutations That Ramp Up Bowel Cancer Risk Cancer Research UK funded scientists have found that people who...
